Global Adrenoleukodystrophy Drugs Market Research Report 2019

Table of Contents

Executive Summary

1 Adrenoleukodystrophy Drugs Market Overview

• 1.1 Product Overview and Scope of Adrenoleukodystrophy Drugs
• 1.2 Adrenoleukodystrophy Drugs Segment by Type
  • 1.2.1 Global Adrenoleukodystrophy Drugs Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Biotin
  • 1.2.3 DRX-065
  • 1.2.4 DUOC-01
  • 1.2.5 Lenti-D
  • 1.2.6 MIN-102
  • 1.2.7 OP-101
  • 1.2.8 Others
• 1.3 Adrenoleukodystrophy Drugs Segment by Application
  • 1.3.1 Adrenoleukodystrophy Drugs Consumption Comparison by Application (2014-2025)
  • 1.3.2 Children
  • 1.3.3 Adult
• 1.3 Global Adrenoleukodystrophy Drugs Market by Region
  • 1.3.1 Global Adrenoleukodystrophy Drugs Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Adrenoleukodystrophy Drugs Market Size
  • 1.4.1 Global Adrenoleukodystrophy Drugs Revenue (2014-2025)
  • 1.4.2 Global Adrenoleukodystrophy Drugs Production (2014-2025)

2 Global Adrenoleukodystrophy Drugs Market Competition by Manufacturers

• 2.1 Global Adrenoleukodystrophy Drugs Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Adrenoleukodystrophy Drugs Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Adrenoleukodystrophy Drugs Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Adrenoleukodystrophy Drugs Production Sites, Area Served, Product Types
• 2.5 Adrenoleukodystrophy Drugs Market Competitive Situation and Trends
  • 2.5.1 Adrenoleukodystrophy Drugs Market Concentration Rate
  • 2.5.2 Adrenoleukodystrophy Drugs Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Adrenoleukodystrophy Drugs Production Market Share by Regions

• 3.1 Global Adrenoleukodystrophy Drugs Production Market Share by Regions
• 3.2 Global Adrenoleukodystrophy Drugs Revenue Market Share by Regions (2014-2019)
• 3.3 Global Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Adrenoleukodystrophy Drugs Production
  • 3.4.1 North America Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
  • 3.4.2 North America Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Adrenoleukodystrophy Drugs Production
  • 3.5.1 Europe Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
  • 3.5.2 Europe Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Adrenoleukodystrophy Drugs Production (2014-2019)
  • 3.6.1 China Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
  • 3.6.2 China Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Adrenoleukodystrophy Drugs Production (2014-2019)
  • 3.7.1 Japan Adrenoleukodystrophy Drugs Production Growth Rate (2014-2019)
  • 3.7.2 Japan Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Adrenoleukodystrophy Drugs Consumption by Regions

• 4.1 Global Adrenoleukodystrophy Drugs Consumption by Regions
• 4.2 North America Adrenoleukodystrophy Drugs Consumption (2014-2019)
• 4.3 Europe Adrenoleukodystrophy Drugs Consumption (2014-2019)
• 4.4 China Adrenoleukodystrophy Drugs Consumption (2014-2019)
• 4.5 Japan Adrenoleukodystrophy Drugs Consumption (2014-2019)

5 Global Adrenoleukodystrophy Drugs Production, Revenue, Price Trend by Type

• 5.1 Global Adrenoleukodystrophy Drugs Production Market Share by Type (2014-2019)
• 5.2 Global Adrenoleukodystrophy Drugs Revenue Market Share by Type (2014-2019)
• 5.3 Global Adrenoleukodystrophy Drugs Price by Type (2014-2019)
• 5.4 Global Adrenoleukodystrophy Drugs Production Growth by Type (2014-2019)

6 Global Adrenoleukodystrophy Drugs Market Analysis by Applications

• 6.1 Global Adrenoleukodystrophy Drugs Consumption Market Share by Application (2014-2019)
• 6.2 Global Adrenoleukodystrophy Drugs Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Adrenoleukodystrophy Drugs Business

• 7.1 Applied Genetic Technologies Corp
  • 7.1.1 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.1.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.1.3 Applied Genetic Technologies Corp Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Bluebird Bio Inc
  • 7.2.1 Bluebird Bio Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.2.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.2.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 MedDay SA
  • 7.3.1 MedDay SA Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.3.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.3.3 MedDay SA Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Minoryx Therapeutics sl
  • 7.4.1 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.4.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.4.3 Minoryx Therapeutics sl Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Pfizer Inc
  • 7.5.1 Pfizer Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.5.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.5.3 Pfizer Inc Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 ReceptoPharm Inc
  • 7.6.1 ReceptoPharm Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.6.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.6.3 ReceptoPharm Inc Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 SOM Biotech SL
  • 7.7.1 SOM Biotech SL Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.7.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.7.3 SOM Biotech SL Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Viking Therapeutics Inc
  • 7.8.1 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production Sites and Area Served
  • 7.8.2 Adrenoleukodystrophy Drugs Product Introduction, Application and Specification
  • 7.8.3 Viking Therapeutics Inc Adrenoleukodystrophy Drugs Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served

8 Adrenoleukodystrophy Drugs Manufacturing Cost Analysis

• 8.1 Adrenoleukodystrophy Drugs Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Adrenoleukodystrophy Drugs
• 8.4 Adrenoleukodystrophy Drugs Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Adrenoleukodystrophy Drugs Distributors List
• 9.3 Adrenoleukodystrophy Drugs Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Adrenoleukodystrophy Drugs Market Forecast

• 11.1 Global Adrenoleukodystrophy Drugs Production, Revenue Forecast
  • 11.1.1 Global Adrenoleukodystrophy Drugs Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Adrenoleukodystrophy Drugs Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Adrenoleukodystrophy Drugs Price and Trend Forecast (2019-2025)
• 11.2 Global Adrenoleukodystrophy Drugs Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Adrenoleukodystrophy Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Adrenoleukodystrophy Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Adrenoleukodystrophy Drugs Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Adrenoleukodystrophy Drugs Production, Revenue Forecast (2019-2025)
• 11.3 Global Adrenoleukodystrophy Drugs Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Adrenoleukodystrophy Drugs Consumption Forecast (2019-2025)
  • 11.3.2 Europe Adrenoleukodystrophy Drugs Consumption Forecast (2019-2025)
  • 11.3.3 China Adrenoleukodystrophy Drugs Consumption Forecast (2019-2025)
  • 11.3.4 Japan Adrenoleukodystrophy Drugs Consumption Forecast (2019-2025)
• 11.4 Global Adrenoleukodystrophy Drugs Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Adrenoleukodystrophy Drugs Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List